PMCTPharmaCountry
    Inicio

Análisis

Análisis en profundidad de mercados farmacéuticos, cadenas de suministro, tecnología y regulación

#4615 ×

Análisis
21 sept 2026•1 min de lectura
BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process
BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.